conv.

All stories
HealthQuiet 4d · day 5

mRNA Melanoma Vaccine's Success Spurs Search for Next Cancer Targets

After Moderna and Merck's melanoma vaccine succeeded in a Phase 3 trial, researchers are extending the mRNA approach to other cancers.

newest coverage 4d agosummary written 4d ago4 pieces2.5k likes & upvotes41 comments MastodonBluesky

What to know

  • Moderna and Merck's mRNA cancer vaccine, intismeran autogene, succeeded in a Phase 3 trial preventing melanoma recurrence, announced this summer.
  • The result was hailed by experts as a breakthrough for mRNA-based cancer treatment technology.
  • Researchers are now investigating whether the same personalized mRNA vaccine approach can be applied to other types of cancer.

Moderna Vaccine developerMerck Vaccine developerCancer researchers Scientists extending the mRNA vaccine platform

How it unfolded 1 development · click the chart to see its coverage posts

Peak 2 pieces in two hours at Sep 19, 4 AM; 4 pieces over 5 days (1 article · 3 posts) Sep 19, 4 AM — 2 pieces · 1 article · 1 post — Mastodon 2Sep 19, 6 AM — quietSep 19, 8 AM — quietSep 19, 10 AM — quietSep 19, 12 PM — quietSep 19, 2 PM — 1 piece · 1 post — Bluesky 1Sep 19, 4 PM — 1 piece · 1 post — Mastodon 1Sep 19, 6 PM — quietSep 19, 8 PM — quietSep 19, 10 PM — quietSep 20, 12 AM — quietSep 20, 2 AM — quietSep 20, 4 AM — quietSep 20, 6 AM — quietSep 20, 8 AM — quietSep 20, 10 AM — quietSep 20, 12 PM — quietSep 20, 2 PM — quietSep 20, 4 PM — quietSep 20, 6 PM — quietSep 20, 8 PM — quietSep 20, 10 PM — quietSep 21, 12 AM — quietSep 21, 2 AM — quietSep 21, 4 AM — quietSep 21, 6 AM — quietSep 21, 8 AM — quietSep 21, 10 AM — quietSep 21, 12 PM — quietSep 21, 2 PM — quietSep 21, 4 PM — quietSep 21, 6 PM — quietSep 21, 8 PM — quietSep 21, 10 PM — quietSep 22, 12 AM — quietSep 22, 2 AM — quietSep 22, 4 AM — quietSep 22, 6 AM — quietSep 22, 8 AM — quietSep 22, 10 AM — quietSep 22, 12 PM — quietSep 22, 2 PM — quietSep 22, 4 PM — quietSep 22, 6 PM — quietSep 22, 8 PM — quietSep 22, 10 PM — quietYesterday, 12 AM — quietYesterday, 2 AM — quietYesterday, 4 AM — quietYesterday, 6 AM — quietYesterday, 8 AM — quietYesterday, 10 AM — quietYesterday, 12 PM — quietYesterday, 2 PM — quietYesterday, 4 PM — quietYesterday, 6 PM — quietYesterday, 8 PM — quietYesterday, 10 PM — quietToday, 12 AM — quiet 1
Sep 20Sep 21Sep 22yesterdaynow · 2:07 AM ET
  1. 1

    Washington Post examines which cancers mRNA vaccines target next

    A Washington Post article reports that the melanoma vaccine's reported success could herald a wave of new mRNA-based treatments for a range of cancers, with researchers now running trials investigating other cancer types.

    “The reported success of an experimental drug that uses messenger RNA to deliver personalized skin cancer vaccines could herald a wave of new treatments that harness the potent technology for a range of cancers, researchers say.”
    — The Washington Post
    1. 1 outlet A melanoma vaccine was hailed as a breakthrough. Which cancers are next?

      first by Mastodon, 4d ago

    • lukeepplin.bsky.social

      Good piece on the breakthrough of mRNA vaccines for melanoma, which my wife was heavily involved in, and the other types of cancer that researchers like her are trying to tackle next. It's an exciting time in that field.

      lukeepplin.bsky.socialBluesky4d ago2.5k▲view on Bluesky ↗
    1 more of the top 2 · 2 posts in this stretch
    • cdarwin@c.im

      The reported success of an experimental drug that uses messenger RNA to deliver personalized skin cancer vaccines could herald a wave of new treatments that harness the potent technology for a range of cancers, researchers say. Drugmakers Moderna and Merck this summer announced that a cancer vaccine, intismeran autogene, had succeeded in a Phase 3…

      cdarwin@c.imMastodon4d agoview on Mastodon ↗
    all of them →
  2. background

    Moderna and Merck report Phase 3 success against melanoma recurrence — Drugmakers Moderna and Merck announced that their cancer vaccine, intismeran autogene, succeeded in a Phase 3 clinical trial in preventing the recurrence of melanoma, a result experts celebrated as a breakthrough for mRNA-based cancer treatments.

What people are saying 0 voices from 0 sites · best of 2 · verbatim